Imunopharm Receives Clinical Trial Approval for CAR-T Drug to Treat Systemic Lupus Erythematosus 10-292024

Learn More

China's First | Imunopharm Receives Clinical Trial Approval for CAR-T Drug in Metastatic Colorectal Cancer 10-122024

Learn More

IM19 Clinical Trial Started 07-072020

Learn More

Immunochina and Edigene announce that they will jointly develop an allogeneic CAR-T therapy for cancer 05-272020

Learn More

Immunochina obtained approval of clinical trial for IM19 CAR-T cells treatment for refractory or relapse acute B-cell lymphoblastic leukemia 04-212020

Learn More